Transatlantic health VC investing $500K–$3M in tech-enabled healthcare and life sciences. Backs global healthcare innovation with checks sized for conviction-stage entry.
InHealth Ventures backs global healthcare innovation from a transatlantic lens — and MOVO-X is exactly that: a Malaysian-origin AI healthcare platform already validated across five countries and four regulatory frameworks (PDPA-MY, PIPEDA, PDPA-SG, CNDP-MA). Our deployment in Canada specifically creates the bridge asset InHealth looks for: a company that travels. We are raising $4M Series A with a proven infrastructure play, not a pilot.
Malaysia's largest private hospital group. Bursa-listed. JCorp majority. 30+ hospitals across 13 Malaysian states. Advanced discussions underway — significant potential for enterprise-wide AI triage, queue management, and kiosk check-in deployment.
Multi-tenant SaaS active across Quebec and Ontario clinic networks. PIPEDA + Law 25 compliant. Interac and Stripe payments. Architecture validated across clinic groups.
Full PDPA (SG), HBRA, and NEHR integration architecture complete. PayNow + NETS + Stripe. English and Mandarin. Strong pipeline potential with Singapore hospital groups.
We'd love to walk you through our product, architecture, and pipeline. If healthcare AI in ASEAN fits your mandate, we should have a conversation.